{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:54:24Z","timestamp":1763016864993},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.beha.2008.02.010","type":"journal-article","created":{"date-parts":[[2008,6,4]],"date-time":"2008-06-04T16:50:22Z","timestamp":1212598222000},"page":"259-270","source":"Crossref","is-referenced-by-count":14,"title":["Prevention of chronic GVHD"],"prefix":"10.1016","volume":"21","author":[{"given":"Jong Wook","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Joachim Deeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2008.02.010_bib1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-126-3-199702010-00002","article-title":"Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects","volume":"126","author":"Duell","year":"1997","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.beha.2008.02.010_bib2","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1182\/blood.V91.10.3637","article-title":"Long-term outcome after marrow transplantation for severe aplastic anemia","volume":"91","author":"Deeg","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib3","unstructured":"Flowers MED, Deeg HJ. Chronic graft-versus-host disease. In: Treleaven J, Barrett AJ, editors. Practical stem cell transplantation. Edinburgh, UK: Elsevier Ltd. p. 9999, in press."},{"key":"10.1016\/j.beha.2008.02.010_bib4","first-page":"197","article-title":"Modification of irradiation injury in mice and guinea pigs by bone marrow injections","volume":"12","author":"Lorenz","year":"1951","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.beha.2008.02.010_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000313050","article-title":"Cellular immunology and the pathogenesis of graft versus host reactions","volume":"15","author":"Elkins","year":"1971","journal-title":"Progress in Allergy"},{"key":"10.1016\/j.beha.2008.02.010_bib6","series-title":"Radiation chimaeras","author":"van Bekkum","year":"1967"},{"key":"10.1016\/j.beha.2008.02.010_bib7","series-title":"The biology of graft-versus-host reactions. The Harvey Lectures","author":"Billingham","year":"1966"},{"key":"10.1016\/j.beha.2008.02.010_bib8","first-page":"226","article-title":"Transfusions et greffes de moelle osseuse homologue chez des humains irradi\u00e9s a haute dose accidentellement","volume":"IV","author":"Math\u00e9","year":"1959","journal-title":"Revue fran\u00e7aise d'\u00e9tudes cliniques et biologiques"},{"key":"10.1016\/j.beha.2008.02.010_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.beha.2008.02.010_bib10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2002-08-2628","article-title":"Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation","volume":"102","author":"Mielcarek","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2141.2005.05458.x","article-title":"Prognostic relevance of \u2018early-onset\u2019 graft-versus-host disease following nonmyeloablative hematopoietic cell transplantation","volume":"129","author":"Mielcarek","year":"2005","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.beha.2008.02.010_bib12","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.beha.2008.02.010_bib13","series-title":"Hematopoietic cell transplantation","first-page":"342","article-title":"Autologous graft-versus-host disease","author":"Hess","year":"1999"},{"key":"10.1016\/j.beha.2008.02.010_bib14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1056\/NEJM198302103080602","article-title":"Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment","volume":"308","author":"Storb","year":"1983","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beha.2008.02.010_bib15","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1200\/JCO.2001.19.16.3685","article-title":"Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis","volume":"19","author":"Cutler","year":"2001","journal-title":"Journal of Clinical Oncology"},{"issue":"Suppl. 1","key":"10.1016\/j.beha.2008.02.010_bib16","first-page":"368a","article-title":"A prospective, randomised trial of peripheral blood stem cells (PBSC) or marrow (BM) for patients undergoing allogeneic transplantation for hematologic malignancies","volume":"94","author":"Bensinger","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib17","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1182\/blood.V98.12.3221","volume":"98","author":"Zaucha","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib18","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood-2002-01-0294","article-title":"Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival","volume":"100","author":"Wagner","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib19","first-page":"250","article-title":"Chronic graft-versus-host disease and other late complications of bone marrow transplantation","volume":"28","author":"Sullivan","year":"1991","journal-title":"Seminars in Hematology"},{"key":"10.1016\/j.beha.2008.02.010_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1034\/j.1600-0609.2001.00331.x","article-title":"An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation","volume":"66","author":"Remberger","year":"2001","journal-title":"European Journal of Haematology"},{"key":"10.1016\/j.beha.2008.02.010_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood-2003-07-2603","article-title":"Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic cell transplants","volume":"103","author":"Randolph","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib22","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2004-09-3660","article-title":"Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission","volume":"105","author":"Miklos","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib23","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2141.1989.tb07768.x","article-title":"Histocompatibility antigen DR4 is associated with chronic graft-versus-host disease in the south Wales population","volume":"73","author":"Holmes","year":"1989","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.beha.2008.02.010_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2141.1990.tb02671.x","article-title":"Chronic graft-versus-host disease and HLA-DR4 in the southern German population","volume":"75","author":"Pawelec","year":"1990","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.beha.2008.02.010_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF02982797","article-title":"The association of HLA antigen and GVHD in allogeneic hemopoietic stem cell transplantation with histocompatible sibling donor: a single-center experience in Korea","volume":"76","author":"Kim","year":"2002","journal-title":"International Journal of Hematology"},{"key":"10.1016\/j.beha.2008.02.010_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.bmt.1704228","article-title":"The effect of hematopoietic growth factors on the risk of graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis","volume":"32","author":"Ho","year":"2003","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.beha.2008.02.010_bib27","first-page":"1062","article-title":"An analysis of factors predisposing to chronic graft-versus-host disease","volume":"13","author":"Ringden","year":"1985","journal-title":"Experimental Hematology"},{"key":"10.1016\/j.beha.2008.02.010_bib28","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.3262237","article-title":"Effects of cyclosporine A on T cell development and clonal deletion","volume":"241","author":"Jenkins","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.beha.2008.02.010_bib29","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1182\/blood-2006-08-042853","article-title":"Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease","volume":"109","author":"Sakoda","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib30","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1182\/blood-2005-09-3623","article-title":"Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations","volume":"107","author":"Zhang","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1532\/IJH97.04015","article-title":"The pathophysiology of chronic graft-versus-host disease","volume":"79","author":"Kansu","year":"2004","journal-title":"International Journal of Hematology"},{"key":"10.1016\/j.beha.2008.02.010_bib32","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood.V98.7.2256","article-title":"Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease","volume":"98","author":"Alpdogan","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib33","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1172\/JCI200317865","article-title":"IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"112","author":"Alpdogan","year":"2003","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.beha.2008.02.010_bib34","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1182\/blood-2002-04-1082","article-title":"Interleukin 7 worsens graft-versus-host disease","volume":"100","author":"Sinha","year":"2002","journal-title":"Blood"},{"issue":"Part 1","key":"10.1016\/j.beha.2008.02.010_bib35","first-page":"149a","article-title":"IL-7 is necessary for induction of experimental graft-versus-host disease (GVHD)","volume":"102","author":"Chung","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib36","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.V97.5.1458","article-title":"Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation","volume":"97","author":"Weinberg","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib37","series-title":"Graft-versus-host disease","year":"2005"},{"key":"10.1016\/j.beha.2008.02.010_bib38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/j.seminhematol.2007.04.009","article-title":"Hematopoietic growth factors including keratinocyte growth factor in allogeneic and autologous stem cell transplantation","volume":"44","author":"Seggewiss","year":"2007","journal-title":"Seminars in Hematology"},{"key":"10.1016\/j.beha.2008.02.010_bib39","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1182\/blood-2004-10-4023","article-title":"New approaches for preventing and treating chronic graft-versus-host disease","volume":"105","author":"Lee","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib40","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.beha.2008.02.010_bib41","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bbmt.2003.08.002","article-title":"Reduced-intensity transplantation for patients with myelodysplastic syndrome achieves durable remission with less graft-versus-host disease","volume":"9","author":"Chan","year":"2003","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.beha.2008.02.010_bib42","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM198005083021901","article-title":"Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia","volume":"302","author":"Blume","year":"1980","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beha.2008.02.010_bib43","first-page":"1490","article-title":"Early diagnosis and treatment of acute human graft-versus-host disease","volume":"15","author":"Ringd\u00e9n","year":"1983","journal-title":"Transplantation Proceedings"},{"key":"10.1016\/j.beha.2008.02.010_bib44","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1182\/blood.V89.10.3880","article-title":"Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial","volume":"89","author":"Deeg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib45","first-page":"86","article-title":"Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease","volume":"2","author":"Chao","year":"1996","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.beha.2008.02.010_bib46","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00007890-198202000-00012","article-title":"Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humans","volume":"33","author":"Atkinson","year":"1982","journal-title":"Transplantation"},{"key":"10.1016\/j.beha.2008.02.010_bib47","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1182\/blood.V59.5.1073.1073","article-title":"Low serum thymic hormone levels in patients with chronic graft-versus-host disease","volume":"59","author":"Atkinson","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/bbmt.2002.v8.pm11939601","article-title":"Intravenous immunoglobulin: appropriate indications and uses in hematopoietic stem cell transplantation","volume":"8","author":"Sokos","year":"2002","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.beha.2008.02.010_bib49","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1182\/blood.V98.13.3868","article-title":"Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial","volume":"98","author":"Kansu","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib50","series-title":"Clinical bone marrow and blood stem cell transplantation","first-page":"416","article-title":"T-cell depletion of allogeneic hematopoietic stem cell grafts","author":"Soiffer","year":"2004"},{"key":"10.1016\/j.beha.2008.02.010_bib51","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(05)66996-6","article-title":"Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial","volume":"366","author":"Wagner","year":"2005","journal-title":"The Lancet"},{"key":"10.1016\/j.beha.2008.02.010_bib52","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1182\/blood.V96.7.2419","article-title":"In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation","volume":"96","author":"Kottaridis","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib53","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1182\/blood.V92.12.4581","article-title":"Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection","volume":"92","author":"Hale","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib54","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.bmt.1705385","article-title":"Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath \u2018in the bag\u2019 as T-cell depletion: the Leiden experience","volume":"37","author":"Barge","year":"2006","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.beha.2008.02.010_bib55","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1200\/JCO.2001.19.4.1152","article-title":"CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors","volume":"19","author":"Soiffer","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.beha.2008.02.010_bib56","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood.V98.10.2942","article-title":"Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)","volume":"98","author":"Bacigalupo","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib57","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbmt.2005.12.034","article-title":"Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation","volume":"12","author":"Bacigalupo","year":"2006","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"Suppl. 1","key":"10.1016\/j.beha.2008.02.010_bib58","first-page":"661a","article-title":"Low dose antithymocyte globulin incorporated into GVHD prophylaxis for matched related donor stem cell transplantation results in low morbidity and no mortality from acute GVHD","volume":"98","author":"Russell","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib59","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.TP.0000133513.29923.44","article-title":"Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation","volume":"78","author":"Remberger","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.beha.2008.02.010_bib60","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.bmt.1701991","article-title":"Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation","volume":"24","author":"Remberger","year":"1999","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.beha.2008.02.010_bib61","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bbmt.2005.12.036","article-title":"Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan\/cyclophosphamide regimen","volume":"12","author":"Deeg","year":"2006","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.beha.2008.02.010_bib62","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.bmt.1704384","article-title":"Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation \u2013 a retrospective analysis","volume":"33","author":"Schetelig","year":"2004","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.beha.2008.02.010_bib63","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/bbmt.2002.v8.pm12374451","article-title":"Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes","volume":"8","author":"Russell","year":"2002","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.beha.2008.02.010_bib64","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1681\/ASN.2006050422","article-title":"A novel mechanism of action for anti-thymocyte globulin: induction of CD4+ CD25+ Foxp3+ regulatory T cells","volume":"17","author":"Lopez","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.beha.2008.02.010_bib65","series-title":"Cellular aspects of autoimmunity. Concepts in immunopathology","first-page":"141","article-title":"Graft-versus-host disease: allo- and autoimmunity after bone marrow transplantation","author":"Shulman","year":"1988"},{"key":"10.1016\/j.beha.2008.02.010_bib66","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1365-2141.2001.03135.x","article-title":"Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients","volume":"115","author":"Maury","year":"2001","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.beha.2008.02.010_bib67","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2006-01-0233","article-title":"Rituximab for steroid-refractory chronic graft-versus-host disease","volume":"108","author":"Cutler","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib68","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1182\/blood-2004-06-2080","article-title":"Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells","volume":"105","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib69","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4049\/jimmunol.170.1.588","article-title":"Antagonist of secondary lymphoid-tissue chemokine (CCR ligand 21) prevents the development of chronic graft-versus-host disease in mice","volume":"170","author":"Sasaki","year":"2003","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.beha.2008.02.010_bib70","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1182\/blood-2004-01-0200","article-title":"Duration of immunosuppressive treatment for chronic graft-versus-host disease","volume":"104","author":"Stewart","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib71","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood-2002-10-3141","article-title":"Performance of a new clinical grading system for chronic graft-versus-host disease: a multi-center study","volume":"102","author":"Akpek","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2008.02.010_bib72","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","article-title":"Chronic graft-versus-host disease","volume":"9","author":"Lee","year":"2003","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.beha.2008.02.010_bib73","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbmt.2006.02.003","volume":"12","author":"Couriel","year":"2006","journal-title":"Biology of Blood and Marrow Transplantation"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169260800011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169260800011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T16:18:22Z","timestamp":1631377102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169260800011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S152169260800011X"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2008.02.010","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}